HLB Life Science has obtained certification under the Medical Device Single Audit Program (MDSAP), an international medical device audit program.


HLB Life Science Obtains Jointly Recognized 'MDSAP' Certification from Five Countries View original image

According to HLB Life Science on June 25, MDSAP is a unified Quality Management System (QMS) certification jointly recognized by regulatory authorities in five countries: the United States, Canada, Australia, Japan, and Brazil. Through a single audit, it verifies the quality management systems of manufacturing facilities. Companies that obtain certification are recognized as having quality management capabilities and regulatory compliance systems that meet international standards.


The scope of the MDSAP certification for HLB Life Science covers key syringe product lines, including disposable syringes, disposable needles, membrane filter syringes, and syringes for cleaning. The certification encompasses the entire process of product design and development, manufacturing, and sales. Through this, HLB Life Science has gained international recognition for the reliability of its quality management system throughout the product lifecycle.


With this certification, the burden of overlapping country-specific inspections is expected to be reduced, enabling shorter overseas regulatory approval timelines and cost savings. In addition, as the quality verification process is streamlined during new contract negotiations with global buyers and international partners, export discussions and business development are also expected to proceed more smoothly.


HLB Life Science plans to accelerate its entry into the Canadian market based on the MDSAP certification. Canada requires MDSAP certification for the import and sale of medical devices, and with this achievement, the company has secured a key requirement for local market entry. HLB Life Science intends to further speed up ongoing export preparations and actively pursue local partnerships and market penetration.



Yoonki Baek, CEO of HLB Life Science, stated, "The MDSAP certification is a meaningful achievement, officially recognizing that the quality management system for our syringe products meets global standards. Building on this, we will expand our entry into key international markets, including Canada, and continuously strengthen our competitiveness in the global medical device market."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing